Trial Profile
A trial of low versus high dose valganciclovir in renal transplant patients for prevention of cytomegalovirus infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 29 Dec 2015 New trial record